When we last talked about Broncus Technologies, it was pulling its initial public offering plans and instead trying to line up venture debt financing. It's done that now, completing a $10 million debt financing ahead of planned $30 million for a Series G round, according to VentureWire.
The Mountain View, Calif.-based Broncus is developing a minimally invasive treatment for emphysema. It has raised over $80 million in its previous four rounds.